{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T17:38:21Z","timestamp":1791221901962,"version":"4.1.0"},"reference-count":114,"publisher":"Consilium Medicum","issue":"5","license":[{"start":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T00:00:00Z","timestamp":1717372800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Terapevticheskii arkhiv"],"abstract":"<jats:p>The use of non-steroidal anti-inflammatory drugs (NSAIDs) for a wide range of diseases is increasing, in part due to an increasing elderly population. Elderly patients are more vulnerable to adverse drug reactions, including side effects and adverse effects of drug-drug interactions, often occurring in this category of patients due to multimorbidity and polypharmacy. One of the most popular NSAIDs in the world is celecoxib. It is a selective cyclooxygenase (COX)-2 inhibitor with 375 times more COX-2 inhibitory activity than COX-1. As a result, celecoxib has a better gastrointestinal tract safety profile than non-selective NSAIDs. Gastrointestinal tolerance is an essential factor that physicians should consider when selecting NSAIDs for elderly patients. Celecoxib can be used in a wide range of diseases of the musculoskeletal system and rheumatological diseases, for the treatment of acute pain in women with primary dysmenorrhea, etc. It is also increasingly used as part of a multimodal perioperative analgesia regimen. There is strong evidence that COX-2 is actively involved in the pathogenesis of ischemic brain damage, as well as in the development and progression of neurodegenerative diseases, such as Alzheimer's disease. NSAIDs are first-line therapy in the treatment of acute migraine attacks. Celecoxib is well tolerated in patients with risk factors for NSAID-associated nephropathy. It does not decrease the glomerular filtration rate in elderly patients and patients with chronic renal failure. Many meta-analyses and epidemiological studies have not confirmed the increased risk of cardiovascular events reported in previous clinical studies and have not shown an increased risk of cardiovascular events with celecoxib, irrespective of dose. COX-2 activation is one of the key factors contributing to obesity-related inflammation. Specific inhibition of COX-2 by celecoxib increases insulin sensitivity in overweight or obese patients. Combination therapies may be a promising new area of treatment for obesity and diabetes.<\/jats:p>","DOI":"10.26442\/00403660.2024.05.202769","type":"journal-article","created":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T14:12:29Z","timestamp":1717423949000},"page":"531-542","source":"Crossref","is-referenced-by-count":4,"title":["Current challenges for therapy of comorbid patients: a new look at celecoxib. A review"],"prefix":"10.26442","volume":"96","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6348-6867","authenticated-orcid":false,"given":"Sergey K.","family":"Zyryanov","sequence":"additional","affiliation":[{"name":"Peoples' Friendship University of Russia named after Patrice Lumumba"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3013-5697","authenticated-orcid":false,"given":"Elena A.","family":"Baybulatova","sequence":"additional","affiliation":[{"name":"Peoples' Friendship University of Russia named after Patrice Lumumba"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"18344","published-online":{"date-parts":[[2024,6,3]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-011-2263-6"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.14336\/AD.2017.0306"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.33029\/9704-7879-0-ANA-2023-1-272"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph19063541"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9343(97)00203-9"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.18433\/j3t886"},{"key":"ref7","unstructured":"Vane JR. The fight against rheumatism: from willow bark to COX-1 sparing drugs. J Physiol Pharmacol. 2000;51(4 Pt. 1):573-86. PMID: 11192932"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2006.12.007"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2004.028886"},{"key":"ref10","unstructured":"Paulson SK, Vaughn MB, Jessen SM, et al. Pharmacokinetics of celecoxib after oral administration in dogs and humans: Effect of food and site of absorption. J Pharmacol Exp Ther. 2001;297(2):638-45. PMID: 11303053"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-023-03571-4"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.anclin.2018.05.001"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1172\/JCI37098"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-200311000-00029"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1213\/01.ANE.0000061461.55712.C5"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1213\/01.ane.0000069507.93582.6e"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/j.0001-5172.2004.00379.x"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1213\/01.ANE.0000100738.05755.6F"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-200502000-00026"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1211\/0022357011778070"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1021\/jm960803q"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1055\/s-0031-1296878"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1001\/jama.282.20.1921"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2005.09.054"},{"key":"ref25","unstructured":"Ishiguro N, Hanaoka A, Okada T, Ito M. Efficacy and safety of celecoxib compared with placebo and etodolac for acute postoperative pain: A multicenter, double-blind, randomized, parallel-group, controlled trial. Nagoya J Med Sci. 2015;77(1-2):81-93. PMID: 25797973"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-140-8-200404200-00010"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1213\/00000539-199377020-00026"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1126\/science.288.5472.1765"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-200212000-00035"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/s1471-4914(02)02383-3"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.pharmtox.42.092401.143905"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.2000.0742094.x"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.21-16-05847.2001"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1038\/35068566"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1152\/jn.2002.87.6.2851"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1378\/chest.125.4.1321"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.5054-03.2004"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1014557107"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1002\/ana.22082"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.1510-05.2005"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-015-0434-1"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0086806"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1016\/j.cobeha.2016.12.003"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2018.00633"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1016\/s0896-6273(02)00794-8"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.2174\/1389450033490902"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0837397100"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2004.01.078"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2013.12.024"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30925-9"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)02143-7"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(21)00395-3"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12103497"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1002\/hup.2401"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.12998\/wjcc.v10.i22.7872"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.3390\/ph3061966"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1111\/head.13663"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.2147\/JPR.S322292"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1007\/s40122-023-00501-5"},{"key":"ref60","unstructured":"Sabzwari SR, Qidwai W, Bhanji S. Polypharmacy in elderly: A cautious trail to tread. J Pak Med Assoc. 2013;63(5):624-7. PMID: 23757993"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afs200"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002296"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-010-0825-2"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1001\/jama.284.10.1247"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)16894-3"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200011233432103"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kel223"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1185\/03007995.2011.581274"},{"key":"ref69","doi-asserted-by":"crossref","unstructured":"Beck LH. Changes in renal function with aging. Clin Geriatr Med. 1998;14(2):199-209. PMID: 9536101","DOI":"10.1016\/S0749-0690(18)30113-7"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V781106"},{"key":"ref71","unstructured":"Lash JP, Gardner C. Effects of aging and drugs on normal renal function. Coron Artery Dis. 1997;8(8-9):489-94. PMID: 9431475"},{"key":"ref72","doi-asserted-by":"crossref","unstructured":"Cooper K, Bennett WM. Nephrotoxicity of common drugs used in clinical practice. Arch Intern Med. 1987;147(7):1213-8. PMID: 3300586","DOI":"10.1001\/archinte.147.7.1213"},{"key":"ref73","doi-asserted-by":"crossref","unstructured":"Blackshear JL, Davidman M, Stillman MT. Identification of risk for renal insufficiency from nonsteroidal anti-inflammatory drugs. Arch Intern Med. 1983;143(6):1130-4. PMID: 6860044","DOI":"10.1001\/archinte.143.6.1130"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1177\/019262339802600504"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1172\/JCI117620"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.30.3.687"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(93)80263-t"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.1997.272.4.F460"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.160.10.1465"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2020.03.023"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.1097\/00045391-200007030-00004"},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1611593"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.1111\/jcpt.12484"},{"key":"ref84","unstructured":"Sherve K, Gerard CJ, Neher JO, St Anna L. Cardiovascular effects of NSAIDs. Am Fam Physician. 2014;90(4). PMID: 25251008"},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0261239"},{"key":"ref86","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-7843.2006.pto_302.x"},{"key":"ref87","doi-asserted-by":"publisher","DOI":"10.1253\/circj.CJ-12-1573"},{"key":"ref88","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.0000014323.99765.16"},{"key":"ref89","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5001766"},{"key":"ref90","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20133115"},{"key":"ref91","doi-asserted-by":"publisher","DOI":"10.1089\/met.2005.3.95"},{"key":"ref92","doi-asserted-by":"publisher","DOI":"10.1007\/s00439-003-1000-y"},{"key":"ref93","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000124718.99562.91"},{"key":"ref94","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2362.2008.02026.x"},{"key":"ref95","doi-asserted-by":"publisher","DOI":"10.1038\/oby.2008.674"},{"key":"ref96","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2006.10.008"},{"key":"ref97","doi-asserted-by":"publisher","DOI":"10.1007\/s13410-015-0355-7"},{"key":"ref98","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2016.1225719"},{"key":"ref99","doi-asserted-by":"publisher","DOI":"10.1185\/03007990903018279"},{"key":"ref100","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/5253623"},{"key":"ref101","doi-asserted-by":"publisher","DOI":"10.1159\/000494130"},{"key":"ref102","doi-asserted-by":"publisher","DOI":"10.23822\/EurAnnACI.1764-1489.98"},{"key":"ref103","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-018-0758-8"},{"key":"ref104","doi-asserted-by":"publisher","DOI":"10.14744\/nci.2021.56667"},{"key":"ref105","doi-asserted-by":"publisher","DOI":"10.2147\/JAA.S164806"},{"key":"ref106","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01193"},{"key":"ref107","doi-asserted-by":"publisher","DOI":"10.3390\/ph17010090"},{"key":"ref108","doi-asserted-by":"publisher","DOI":"10.1159\/000085794"},{"key":"ref109","doi-asserted-by":"publisher","DOI":"10.4414\/smw.2006.11358"},{"key":"ref110","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S180261"},{"key":"ref111","doi-asserted-by":"publisher","DOI":"10.1111\/pme.12282"},{"key":"ref112","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.13702"},{"key":"ref113","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1991.tb03867.x"},{"key":"ref114","doi-asserted-by":"publisher","DOI":"10.2147\/TCRM.S79135"}],"container-title":["Terapevticheskii arkhiv"],"original-title":[],"link":[{"URL":"https:\/\/ter-arkhiv.ru\/0040-3660\/article\/viewFile\/632963\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ter-arkhiv.ru\/0040-3660\/article\/viewFile\/632963\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T13:12:06Z","timestamp":1733231526000},"score":1,"resource":{"primary":{"URL":"https:\/\/ter-arkhiv.ru\/0040-3660\/article\/view\/632963"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,3]]},"references-count":114,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,6,3]]}},"URL":"https:\/\/doi.org\/10.26442\/00403660.2024.05.202769","relation":{},"ISSN":["2309-5342","0040-3660"],"issn-type":[{"value":"2309-5342","type":"electronic"},{"value":"0040-3660","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6,3]]}}}